Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
55
days
Efficacy and safety of IL-23p19 antagonists versus placebo in inflammatory bowel disease: a systematic review and meta‑analysis of randomized controlled trials
AuthorsXi-Yuan Peng; Wei Du; Juan Miao; Li Shi; Wei Li; Meng-Wei Ge; Lu-Ting Shen; Rui Feng; Kang Zhong; Si-Qi Gao; Hong-Lin Chen
Affiliations1. School of Nursing and Rehabilitation, Nantong University, Nantong, People’s Republic of China
52
days
Islamic reasoning and the use of prohibited medicines among Muslim patients: a qualitative study
AuthorsZachariah Nazar; Bilal Ali; Paul Rutter; Nicola Barnes
Affiliations1. College of Pharmacy, QU Health, Qatar University, Doha, Qatar; 2. School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, England
46
days
Economics, efficacy and safety of five traditional Chinese medicine injections plus chemotherapy as adjuvant therapy for non-small cell lung cancer: A network meta-analysis
AuthorsKai Xu; Hongtao Li; Yulu Zhu; Zhuying Jing; Lihong Gao; Yuyang Sun; Baolong Ding; Hongting Yao; Hui Wang; Xin Li
Affiliations1. Department of Pharmacy, The Second People’s Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, China; 2. Department of Pharmaceutical Regulatory Science and Pharmacoeconomics, School of Pharmacy, Nanjing Medical University, Nanjing, People’s Republic of China; 3. Department of Radiology, Nanjing City QiXia District Qixia Community Healthcare Center, Nanjing, China; 4. Department of Health Policy, School of Health Policy and Management, Nanjing Medical University, Nanjing, China; 5. Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China
99
days
Medication safety in patients with hepatic disease: proof of concept of a new approach to screen for patients at risk—a retrospective evaluation utilizing electronic prescribing systems
AuthorsDorothea Strobach; Alina Grebe; Julian Steinbrech; Maximilian Günther; Martin J. Hug
Affiliations1. Hospital Pharmacy, University Hospital LMU Munich, Munich, Germany; 2. Doctoral Program Clinical Pharmacy, University Hospital, LMU Munich, Munich, Germany; 3. Hospital Pharmacy, Medical Center – University of Freiburg, Freiburg, Germany; 4. Institute of Pharmaceutical Sciences, University of Freiburg, Freiburg, Germany
53
days
Exploring pediatricians’ off-label prescribing behavior in China: A theory of planned behavior-based study
AuthorsYueqin Zhang; Xuelin Sun; Dong Wang; Yiming Hua; Gang Wang; Nelson Ramalho
Affiliations1. Department of Pharmacy, Beijing Aerospace General Hospital, Beijing, China; 2. Department of Pharmacy, Beijing Hospital, Beijing, China; 3. School of Health Management, Southern Medical University, Guangzhou, China; 4. Department of Pharmacy, Xuanwu Hospital Capital Medical University, Beijing, China; 5. Department of President’s Office, Beijing Aerospace General Hospital, Beijing, China; 6. BRU-Business Research Unit, ISCTE Instituto Universitario de Lisboa, Lisbon, Portugal
35
days
Comparative evaluation of pregnancy-related adverse events associated with proton pump inhibitors using the FDA adverse event reporting system database
AuthorsWenjuan Dong; Yuye Ran; Yiwen Cai; Yong Yang; Hailin Liu
Affiliations1. Department of Pharmacy, People’s Hospital of Chongqing Liangjiang New Area, Chongqing, China; 2. Department of Pharmacy, Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Chengdu, China; 3. Department of Pharmacy, Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
76
days
Real-world safety assessment of ublituximab: a pharmacovigilance analysis based on the FDA adverse event reporting system
AuthorsSen Luo; Yining Feng; Zhuo Huang; Duo Zhang; Xu Gao; Chengyan Liu; Zeyu Liu; Kaidi Zhao; Run Tian; Xin Huang
Affiliations1. Department of Bone and Joint Surgery, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China; 2. Department of Anesthesia, Xi’an Honghui Hospital, Xi’an, China; 3. Department of Orthopedics, Xi’an Honghui Hospital, Xi’an, China; 4. Department of Dermatology, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China; 5. Department of Cardiology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
79
days
Comparative risks of inflammatory bowel disease in patients with type 2 diabetes mellitus treated with SGLT-2 inhibitors versus DPP-4 inhibitors: a real-world nationwide cohort study
AuthorsYa-Ju Yu; Wu-Chien Chien
Affiliations1. Graduate Institute of Life Sciences, College of Biomedical Sciences, National Defense Medical University, Taipei City, Taiwan, ROC; 2. Department of Medical Research, Tri-Service General Hospital, Taipei City, Taiwan, ROC
91
days
Effectiveness and safety of different antiplatelet therapies for minor ischemic stroke or high-risk transient ischemic attack: a systematic review and network meta-analysis
AuthorsTingting Jin; Huifang Jiang; Guoquan Chen; Meng Chen; Yangmin Hu; Lingyan Yu; Jie Chen; Wei Hu; Haibin Dai
Affiliations1. Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; 2. Department of Pharmacy, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China
175
days
Addressing potentially inappropriate prescribing in care homes: regional evaluation of a pharmacist-led model in Northern Ireland
AuthorsAnn Sinéad Doherty; Gary Adamson; John Mallett; Carmel Darcy; Hilary McKee; Anne Friel; Michael G. Scott; E. F. Ruth Miller
Affiliations1. School of Psychology, Ulster University, Coleraine, UK; 2. Department of General Practice, University College Cork, Cork, Ireland; 3. Pharmacy, Altnagelvin Area Hospital, Western Health and Social Care Trust, Derry, UK; 4. Northern Health and Social Care Trust, Antrim, UK; 5. Medicines Optimisation and Innovation Centre, Pine House Antrim Area Hospital Site, Northern Health and Social Care Trust, Antrim, UK; 6. Northern Ireland Centre for Pharmacy Learning and Development, Queen’s University Belfast, Belfast, UK
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days